United Therapeutics Corporation (UTHR)
Market Closed
1 Sep, 20:00
$
512. 70
+2.32
+0.4546%
$
21.66B Market Cap
11.96 P/E Ratio
- Div Yield
456,329 Volume
24.04 Eps
$ 510.38
Previous Close 
Want to track UTHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
United Therapeutics Corporation (UTHR) Statistics
Valuation metrics
Market Cap 21.66B
Enterprise value 20.08B
Trailing P/E (ttm) 17.05
Forward P/E -
PEG ratio 1.87
Price/Sales (ttm) 6.94
Price/Book (mrq) 3.43
Enterprise Value/Revenue 6.36
Enterprise Value/EBITDA 12.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 349.48K
Average volume (90 days) 459.78K
Price summary
52-Week low 375.61
52-Week high 609.35
Beta -
50-Day moving average 522.92
200-Day moving average 543.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 23 Sep 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.42%
Operating margin 0.44%
Operational effectiveness
Return on assets 0.18%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 74.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 30.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 62.5
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 5.73%
Book value per share (mrq) 150.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
